Leilei Li

机构：Shandong University, National Medical Products Administration · ORCID：0000-0002-2989-6942

发表论文 59 篇 · 总被引 608 次 · h-index 12

代表论文

• EMT and Cancer Cell Stemness Associated With Chemotherapeutic Resistance in Esophageal Cancer (2021 · Frontiers in Oncology · 被引 48)
• Luteolin attenuates cancer cell stemness in PTX-resistant oesophageal cancer cells through mediating SOX2 protein stability (2021 · Pharmacological Research · 被引 44)
• Luteolin combined with low‐dose paclitaxel synergistically inhibits epithelial–mesenchymal transition and induces cell apoptosis on esophageal carcinoma in vitro and in vivo (2021 · Phytotherapy Research · 被引 29)
• Discovery of chalcone-modified estradiol analogs as antitumour agents that Inhibit tumour angiogenesis and epithelial to mesenchymal transition (2019 · European Journal of Medicinal Chemistry · 被引 20)
• A case of fatal poisoning caused by etomidate: evidence from pathological and toxicological analyses (2024 · Forensic Science Medicine and Pathology · 被引 12)
• The mechanism by which SIRT1 regulates autophagy and EMT in drug-resistant oesophageal cancer cells (2024 · Life Sciences · 被引 6)